The use of Fourier analysis in the calculation of trough to peak ratio from ambulatory blood pressure measurements

Journal of Human Hypertension

Volumn 12, Issue 1, 1998, Pages 61-67

  Diamant, M ^a,c   Idema, R N ^b   Vincent, H H ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b Holy Hospital   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ambulatory monitoring; Antihypertensive drugs; Fourier analysis; Time block analysis; Trough to peak ratio

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; FOURIER ANALYSIS; HUMAN; MALE; MEAN ARTERIAL PRESSURE;

EID: 0031985874     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000546     Document Type: Article

References (26)

1. Rose M, McMahon FG. Some problems with anti-hypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990; 3: 151-155.
2. Elliot HL, Meredith PA. Methodological considerations in the calculation of the trough:peak ratio. J Hypertens 1994; 12 (Suppl 8): S3-S7.
3. Zanchetti A (on behalf of the Italian nifedipine GITS study group). Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 1994; 12 (Suppl 8): S97-S106.
4. Elliot HL, Meredith PA. Trough/peak ratio: clinically useful or practically irrelevant? J Hypertens 1995; 13: 279-283.
5. Gama G, Santos A, Polónia J. Measurement of trough-to-peak ratios of four anti-hypertensive drugs on the basis of 24 h ambulatory blood pressure monitoring: different methods may give different results. J Hum Hypertens 1995; 7: 575-580.
6. Myers MG. Trough-to-peak ratio and 24-hour blood pressure control: Methodological issues. Am J Hypertens 1995; 8: 214-219.
7. White WB. Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991; 9 (Suppl 1): S27-S32.
8. Cesarone MR et al. Effects of trandolapril on 24-h ambulatory blood pressure in patients with mild-to-moderate essential hypertension. J Cardiovasc Pharmacol 1994; 23 (Suppl 4): S65-S72.
9. Fortini A, Cappelletti C, Cecchi L, Laureano R. Fosinopril in the treatment of hypertension: effects on 24h ambulatory blood pressure and on blood pressure response to exercise. J Hum Hypertens 1994; 8: 469-474.
10. Mancia G and the Italian Trandolapril Study Group. Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. Am J Cardiol 1992; 70: 60D-66D.
11. Thijs L, Staessen J, Fagard R. Analysis of the diurnal blood pressure curve. High Blood Press 1992, 1: 17-28.
12. Machnig T et al. A new approach for evaluating circadian blood pressure levels and variability from 24 h ambulatory blood pressure profiles. Am J Hypertens 1993; 6: 248-252.
13. Chau NP et al. Twenty-four-hour blood pressure in shift workers. Circulation 1991; 80: 341-347.
14. Streitberg B, Meyer-Sabellek W. Smoothing twenty-four-hour ambulatory blood pressure profiles: a comparison of alternative methods. J Hypertens 1990; 8 (Suppl 6): S21-S27.
15. Staessen J, Bulpitt CJ, Fagard R. Reference values for the ambulatory blood pressure and the blood pressure measured at home: a population study. J Hum Hypertens 1991; 5: 355-361.
16. Staessen J et al. The diurnal blood pressure profile: a population study. Am J Hypertens 1992; 5: 386-392.
17. Ménard J, Chatellier G, Day M, Vaur L. Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens 1994; 12 (Suppl 8): S21-S25.
18. Cappuccio FP, Markandu ND, Singer DRJ, MacGregor GA. Amlodipine and lisinopril in combination for the treatment of essential hypertension: efficacy and predictors of response. J Hypertens 1993; 11: 839-847.
19. Trazzi S et al. Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens 1991; 9: 115-119.
20. White W. The role of ambulatory monitoring of the blood pressure for assessment of antihypertensive agents. J Clin Pharmacol 1991; 32: 524-528.
21. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens 1995; 13: 1105-1112.
22. Dupont AG, Van der Nieppen P, Six RO. Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol 1987; 24: 106-109.
23. Mancia G et al. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995; 8: 311-315.
24. Staessen JA et al, on behalf of the APTH Investigators: The trough-to-peak ratio as an instrument to evaluate antihypertensive drugs. Hypertension 1995; 26 [part 1]: 942-949.
25. Prasad N, MacFadyen RJ, Ogston SA, MacDonald TM. Elevated blood pressure during the first two hours of ambulatory blood pressure monitoring: a study comparing consecutive twenty-four-hour monitoring periods. J Hypertens 1995; 13: 291-295.
26. Morgan T, Anderson A. Clinical efficacy of perindopril in hypertension. Clin Exp Pharmacol Physiol 1992; 10 (Suppl 19): 61-65.